| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Product sales, net | ||||||
2,513 | 2,076 | - | ||||
Costs and operating expenses: | ||||||
Cost of product sales | ||||||
805 | 422 | - | ||||
Research and development | ||||||
117,363 | 205,319 | 32,527 | ||||
Selling, general and administrative | ||||||
57,218 | 31,366 | 5,985 | ||||
Total costs and operating expenses | ||||||
175,386 | 237,107 | 38,512 | ||||
Loss from operations | ||||||
-172,873 | -235,031 | -38,512 | ||||
Other income (expense): | ||||||
Interest income | ||||||
7,362 | 1,116 | - | ||||
Interest expense | ||||||
1,538 | - | - | ||||
Other income (expense), net | ||||||
1,387 | 4,390 | -1,179 | ||||
Total other income (expense), net | ||||||
7,211 | 5,506 | -1,179 | ||||
Net loss before income tax | ||||||
-165,662 | -229,525 | -39,691 | ||||
Income tax (expense) benefit | ||||||
-2,240 | 970 | 53 | ||||
Net loss attributable to ordinary shareholders | ||||||
-163,422 | -230,495 | -39,744 | ||||
Other comprehensive income (loss): | ||||||
Foreign currency translation adjustment | ||||||
-1,387 | -964 | 4,398 | ||||
Unrealized loss on marketable securities | ||||||
266 | - | - | ||||
Total other comprehensive income (loss): | ||||||
-1,121 | -964 | 4,398 | ||||
Total comprehensive loss | ||||||
-164,543 | -231,459 | -35,346 | ||||
Net loss per share attributable to ordinary shareholders, basic and diluted | ||||||
-1.75 | -10.22 | -4.48 | ||||
Weighted average number of ordinary shares outstanding, basic and diluted | ||||||
93,240 | 22,559 | 8,872 | ||||